Intuitive Secures US FDA Nod For 5th Generation Robotic System

Intuitive medical device firm and the innovation leader in minimally invasive care has secured the US FDA endorsement for da Vinci 5, the organization's cutting-edge multiport robotic system.  

“We are pleased to receive FDA clearance for our fifth-generation robotic system, da Vinci 5. We are committed to meaningful improvements in surgery that enable better patient outcomes, enhance the patient and care team experiences, and ultimately lower the total cost of care. After more than a decade of careful research, design, development and testing, we believe da Vinci 5 will deliver on these goals and help drive the future of robotic-assisted surgery,” said Gary Guthart, CEO. Da Vinci 5 expands on Intuitive’s da Vinci Xi's profoundly practical plan, which surgeons and care groups all over the globe have utilized over 7 million methodologies to date. The framework incorporates more than 150 improvements, including:

It further developed exactness and accuracy, Cutting edge 3D showcase and picture handling, First-of-its-sort force-detecting innovation, including an enhanced UI, with settings that are available by the more extensive surgical group, Extended computing power and high-level information capacities and permitting surgeons to track down their best fit for surgical viewing and solace, including the capacity to sit upstanding.

Da Vinci 5 will first be accessible to a few customers in the US who teamed up with Intuitive during the improvement time frame and those with mature automated medical procedure programs. Intuitive will work with specialists at these underlying locales to create extra information on the framework's utilization before a more extensive business introduction.

“We strive to provide customers with technology that meets their needs and solves important problems,” said Dr Myriam J. Curet, chief medical officer, Intuitive. “We intend to launch da Vinci 5 more broadly in the US and globally after we learn from and work with an initial smaller number of customers directly. We design our systems so we can integrate new functions, capabilities, indications, and instrumentation over time. Our careful attention to customers’ long-term needs and goals has led our systems to become the hospital standard, and we expect to continue developing and innovating da Vinci 5 and da Vinci Xi over the coming years,”  said Curet.